These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20442441)

  • 21. Detection of DNA repair protein in colorectal cancer of patients up to 50 years old can increase the identification of Lynch syndrome?
    Germini DE; Mader AM; Gomes LG; Teodoro TR; Franco MI; Waisberg J
    Tumour Biol; 2016 Feb; 37(2):2757-64. PubMed ID: 26408182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Universal testing of colorectal cancer for deficient mismatch repair - a new era has arrived.
    Clark S
    Colorectal Dis; 2017 Sep; 19(9):801-802. PubMed ID: 28872265
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hicks SC; Ward RL; Hawkins NJ
    Pathology; 2011 Jan; 43(1):84-5; author reply 85-6. PubMed ID: 21240077
    [No Abstract]   [Full Text] [Related]  

  • 24. Cumulative incidence of metachronous colorectal cancer risk for mismatch repair gene mutation carriers is overestimated.
    Renehan AG
    Gut; 2012 May; 61(5):783; author reply 783-4. PubMed ID: 21873468
    [No Abstract]   [Full Text] [Related]  

  • 25. Mismatch repair deficiency in Lynch syndrome-associated colorectal adenomas is more prevalent in older patients.
    Tanaka M; Nakajima T; Sugano K; Yoshida T; Taniguchi H; Kanemitsu Y; Nagino M; Sekine S
    Histopathology; 2016 Aug; 69(2):322-8. PubMed ID: 26826556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D).
    Vasen HF; Ghorbanoghli Z; Bourdeaut F; Cabaret O; Caron O; Duval A; Entz-Werle N; Goldberg Y; Ilencikova D; Kratz CP; Lavoine N; Loeffen J; Menko FH; Muleris M; Sebille G; Colas C; Burkhardt B; Brugieres L; Wimmer K;
    J Med Genet; 2014 May; 51(5):283-93. PubMed ID: 24556086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is prostate cancer a Lynch syndrome cancer?
    Win AK
    Asian J Androl; 2013 Sep; 15(5):588-9. PubMed ID: 23817498
    [No Abstract]   [Full Text] [Related]  

  • 28. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
    J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted next-generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families.
    Talseth-Palmer BA; Bauer DC; Sjursen W; Evans TJ; McPhillips M; Proietto A; Otton G; Spigelman AD; Scott RJ
    Cancer Med; 2016 May; 5(5):929-41. PubMed ID: 26811195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Selection criteria for search for germ mutations in colorectal cancer hereditary nonpolyposis].
    Ríos A; Rodríguez JM; Carbonel P; Parrilla P
    Med Clin (Barc); 2015 Feb; 144(4):185-6. PubMed ID: 25458510
    [No Abstract]   [Full Text] [Related]  

  • 31. Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines.
    Balmaña J; Balaguer F; Cervantes A; Arnold D;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi73-80. PubMed ID: 23813931
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
    Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
    Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lynch syndrome: a pediatric perspective.
    Huang SC; Durno CA; Erdman SH
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):144-52. PubMed ID: 24051481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current clinical topics of Lynch syndrome.
    Tanakaya K
    Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mismatch repair gone awry: Management of Lynch syndrome.
    Zhang T; Boswell EL; McCall SJ; Hsu DS
    Crit Rev Oncol Hematol; 2015 Mar; 93(3):170-9. PubMed ID: 25459670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer.
    Boland CR; Shike M
    Gastroenterology; 2010 Jun; 138(7):2197.e1-7. PubMed ID: 20416305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HNPCC (hereditary non-polyposis colorectal cancer) or Lynch syndrome: a syndrome related to a failure of DNA repair system].
    Manceau G; Karoui M; Charachon A; Delchier JC; Sobhani I
    Bull Cancer; 2011 Mar; 98(3):323-36. PubMed ID: 21459714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome).
    Lynch HT; Lynch JF; Lynch PM
    J Natl Cancer Inst; 2007 Feb; 99(4):261-3. PubMed ID: 17312298
    [No Abstract]   [Full Text] [Related]  

  • 40. Dawning of the epigenetic era in hereditary cancer.
    Hitchins MP; Lynch HT
    Clin Genet; 2014 May; 85(5):413-6. PubMed ID: 24588205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.